Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial

Professor Andrew Stevens (Vice-chairman) Professor of Public Health, University of Birmingham Professor Ray Tallis Consultant Physician, Hope Hospital, Salford Dr Cathryn Thomas General Practitioner, and Senior Lecturer, Department of Primary Care and General Practice, University of Birmingham Professor Mary Watkins Head of Institute of Health Studies, University of Plymouth Dr Norman Waugh Public Health Consultant, University of Southampton 9 Sources of evidence considered by the committee The following documentation and opinion were made available to the committee: Assessment report prepared by the Liverpool Reviews and Implementation Group, Department of Pharmacology and Therapeutics, University of Liverpool: Early Thrombolysis for the Treatment of Acute Myocardial Infarction, April 2002. Manufacturer or sponsor submissions: • Aventis Behring • Boehringer Ingelheim • Roche Professional or specialist and patient or carer group submissions: • British Association for Immediate Care • British Association for Nursing in Cardiac Care • British Heart Foundation • Faculty of Accident & Emergency Medicine and British Association of Accident and Emergency Medicine • Faculty of Pre-Hospital Care, Royal College of Surgeons, Edinburgh • Joint Royal Colleges Ambulance Liaison Committee and Ambulance Service Association • Primary Care Cardiovascular Society • Royal College of Physicians and British Cardiac Society • Warwickshire Health Authority •
